This is the classic website, which will be retired eventually. Please visit the modernized instead.

Key Record Dates Identifier: NCT04576156
Brief Title: A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

First Submitted : September 18, 2020
First Submitted that Met QC Criteria : October 2, 2020
First Posted : October 6, 2020

Last Update Submitted that Met QC Criteria : April 15, 2024
Last Update Posted : April 16, 2024 (Estimate)